World's Best Scientists 2026 revealed!
Claes G. Tropé

Claes G. Tropé

D-Index & Metrics

Medicine

D-Index
82
Citations
26205
World Ranking
16054
National Ranking
78

Claes G. Tropé publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Claes G. Tropé sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 504 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Claes G. Tropé D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Claes G. Tropé sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 1992 - Member of Academia Europaea

Overview

Claes G. Tropé is affiliated with the University of Oslo in Norway. Their academic activities are recognized through membership in Academia Europaea, an association to which they were admitted in 1992.

Details about Claes G. Tropé's recent research publications, main fields of study, subfields, and defined topics of work have not been provided. There is also no available information on frequent co-authors, publication venues, or book publications associated with this researcher.

The membership in Academia Europaea indicates involvement in a network of distinguished researchers across Europe. However, specific areas of focus or research contributions as documented through papers or other scholarly outputs are not listed here.

This profile highlights Claes G. Tropé's institutional affiliation and recognition but lacks further bibliometric or topical data that would provide insight into their research scope or output.

Best Publications

  • Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

    Ignace Vergote;Claes G. Tropé;Frédéric Amant;Gunnar B. Kristensen

  • Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

    MK Parmar;JA Ledermann;N Colombo;Bois A Du

  • Randomized Intergroup Trial of Cisplatin–Paclitaxel Versus Cisplatin–Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results

    Martine J. Piccart;Kamma Bertelsen;Keith James;Jim Cassidy

  • Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma

    Ignace Vergote;Jos De Brabanter;Anthony Fyles;Kamma Bertelsen

  • Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma

    Sivan Elloul;Mari Bukholt Elstrand;Jahn M. Nesland M.D.;Claes G. Tropé M.D.

  • Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis

    Einar K Rofstad;K. Sundfør;Heidi Lyng;Claes G. Tropé

  • Tumor Size, Depth of Invasion, and Grading of the Invasive Tumor Front Are the Main Prognostic Factors in Early Squamous Cell Cervical Carcinoma

    Gunnar B. Kristensen;Vera M. Abeler;Bjørn Risberg;Claes Tropé

  • A retrospective study of 370 borderline tumors of the ovary treated at the norwegian radium hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities

    Janne Kærn;Claes G. Tropé M.D.;Vera M. Abeler M.D.

  • Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin

    Joon Tae Park;Xu Chen;Claes G. Tropè;Claes G. Tropè;Ben Davidson

  • Carcinoma of the fallopian tube.

    Mark Baekelandt;Anne Jorunn Nesbakken;Gunnar B. Kristensen;Claes G. Tropé

  • Diagnosis and treatment of sarcoma of the uterus. A review

    Claes G. Tropé;Vera M. Abeler;Gunnar B. Kristensen

  • Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals.

    T. Paulsen;Kristina Kjærheim;J. Kærn;Steinar Tretli

  • NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma.

    Hiep Phuc Dong;Mari Bunkholt Elstrand;Arild Holth;Ilvars Silins

  • Epithelial ovarian carcinoma

    Gunnar B Kristensen;Claes Tropé

  • DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9 , HOXB5 , SCGB3A1 , and CRABP1 as novel targets

    Qinghua Wu;Ragnhild Lothe;Ragnhild Lothe;Terje Cruickshank Ahlquist;Terje Cruickshank Ahlquist;Ilvars Silins

  • Epithelial-mesenchymal transition in ovarian carcinoma.

    Ben Davidson;Claes Göran Trope;Reuven Reich

  • Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse

    Ignace B. Vergote;Janne Kærn;Vera M. Abeler;Erik O. Pettersen

  • Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern.

    Vera M. Abeler;Ignace B. Vergote;Kjell E. Kjørstad;Claes G. Tropé

  • Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer

    Martin J. Piccart;K. Bertelsen;G. Stuart;J. Cassidy

  • Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: new aspects and multivariate analysis.

    Amin P.H. Makar;Gunnar B. Kristensen;Janne Kærn;Ole P. Børmer

Frequent Co-Authors

Ben Davidson
Ben Davidson Oslo University Hospital
Jahn M. Nesland
Jahn M. Nesland Oslo University Hospital
Gunnar B. Kristensen
Gunnar B. Kristensen Oslo University Hospital
Sverre Heim
Sverre Heim Oslo University Hospital
Sophie D. Fosså
Sophie D. Fosså Oslo University Hospital
Ragnhild A. Lothe
Ragnhild A. Lothe University of Oslo
Ioannis Panagopoulos
Ioannis Panagopoulos Oslo University Hospital
Ie Ming Shih
Ie Ming Shih Johns Hopkins University
Jonathan S. Berek
Jonathan S. Berek Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

There are many online degree options for those seeking to build a career in healthcare, both before and after medical school. Students wanting strong leadership skills often pursue cahme accredited online mha programs, which provide industry-recognized training in healthcare administration.

For nurses seeking flexible advancement, alternatives like rn to bsn no clinical hours pathways allow working RNs to earn a bachelor’s degree without traditional on-site clinical requirements. This makes juggling work and further study more feasible.

Nurses aiming for top-level practice and leadership may look into accelerated msn to dnp programs, which fast-track the journey to a Doctor of Nursing Practice. Those seeking less intensive options will find a range of dnp programs online that emphasize both convenience and high educational standards.

Choosing the right online degree or certification can open a variety of pathways in the fast-evolving medical and healthcare fields, offering flexibility and specialization to suit your career goals.

Best Scientists Citing Claes G. Tropé

Trending Scientists